Neurofibromatosis Type 2 (NF2) Latest Advances

[89Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic NF2-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trial.

Journal: BMJ open

Published: April 08, 2026

Retraction Note: Facial nerve preservation following gamma knife radiosurgery for vestibular schwannomas in neurofibromatosis type 2: a systematic review and meta-analysis of 552 tumors.

Journal: Neurosurgical review

Published: March 27, 2026

Large Sporadic Vestibular Schwannoma Causing Brainstem Compression and Obstructive Hydrocephalus in a Young Adult.

Journal: Cureus

Published: March 09, 2026

Repeated Latency Prolongation of the Orbicularis Oris Muscle During Intraoperative Transcranial Facial Motor Evoked Potential Monitoring: A Case Report.

Journal: Cureus

Published: March 06, 2026

BRCA2 and NF2-Mutated High-Grade Renal Cell Carcinoma: A Case Report and Literature Review.

Journal: International journal of surgical pathology

Published: February 24, 2026

RETRACTION: Neurofibromatosis Type 2 Versus Sporadic Vestibular Schwannoma: The Utility of MR Diffusion and Dynamic Contrast-Enhanced Imaging.

Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging

Published: February 06, 2026

Targeted Medical Therapy for Vestibular Schwannomas: Evidence, Limits, and Future Directions-A Scoping Review.

Journal: Current issues in molecular biology

Published: January 31, 2026

Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.

Journal: Science advances

Published: January 30, 2026

Emerging Molecular Insights and Therapeutic Directions in Neurofibromatosis Type 1 and NF2-Related Schwannomatosis.

Journal: International journal of molecular sciences

Published: January 09, 2026

Flame-shaped epiretinal membranes: expanding the spectrum beyond neurofibromatosis type 2.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: December 27, 2025

Building a framework for adolescent and young adult transition of care for patients with neurofibromatosis type 1 and neurofibromatosis type 2-related schwannomatosis syndromes.

Journal: Frontiers in oncology

Published: December 23, 2025

Case Report: Somatic NF2 mutation in a vestibular schwannoma arising in a patient with neurofibromatosis type 1.

Journal: Frontiers in oncology

Published: December 17, 2025

Neurofibromatosis Type 2 (NF2) Latest Advances

Find the Latest Research About Neurofibromatosis Type 2 (NF2)

[89Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic NF2-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trial.

[89Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic NF2-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trial.

Retraction Note: Facial nerve preservation following gamma knife radiosurgery for vestibular schwannomas in neurofibromatosis type 2: a systematic review and meta-analysis of 552 tumors.

Retraction Note: Facial nerve preservation following gamma knife radiosurgery for vestibular schwannomas in neurofibromatosis type 2: a systematic review and meta-analysis of 552 tumors.

Large Sporadic Vestibular Schwannoma Causing Brainstem Compression and Obstructive Hydrocephalus in a Young Adult.

Large Sporadic Vestibular Schwannoma Causing Brainstem Compression and Obstructive Hydrocephalus in a Young Adult.

Repeated Latency Prolongation of the Orbicularis Oris Muscle During Intraoperative Transcranial Facial Motor Evoked Potential Monitoring: A Case Report.

Repeated Latency Prolongation of the Orbicularis Oris Muscle During Intraoperative Transcranial Facial Motor Evoked Potential Monitoring: A Case Report.

BRCA2 and NF2-Mutated High-Grade Renal Cell Carcinoma: A Case Report and Literature Review.

BRCA2 and NF2-Mutated High-Grade Renal Cell Carcinoma: A Case Report and Literature Review.

RETRACTION: Neurofibromatosis Type 2 Versus Sporadic Vestibular Schwannoma: The Utility of MR Diffusion and Dynamic Contrast-Enhanced Imaging.

RETRACTION: Neurofibromatosis Type 2 Versus Sporadic Vestibular Schwannoma: The Utility of MR Diffusion and Dynamic Contrast-Enhanced Imaging.

Targeted Medical Therapy for Vestibular Schwannomas: Evidence, Limits, and Future Directions-A Scoping Review.

Targeted Medical Therapy for Vestibular Schwannomas: Evidence, Limits, and Future Directions-A Scoping Review.

Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.

Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.

Emerging Molecular Insights and Therapeutic Directions in Neurofibromatosis Type 1 and NF2-Related Schwannomatosis.

Emerging Molecular Insights and Therapeutic Directions in Neurofibromatosis Type 1 and NF2-Related Schwannomatosis.

Flame-shaped epiretinal membranes: expanding the spectrum beyond neurofibromatosis type 2.

Flame-shaped epiretinal membranes: expanding the spectrum beyond neurofibromatosis type 2.

Building a framework for adolescent and young adult transition of care for patients with neurofibromatosis type 1 and neurofibromatosis type 2-related schwannomatosis syndromes.

Building a framework for adolescent and young adult transition of care for patients with neurofibromatosis type 1 and neurofibromatosis type 2-related schwannomatosis syndromes.

Case Report: Somatic NF2 mutation in a vestibular schwannoma arising in a patient with neurofibromatosis type 1.

Case Report: Somatic NF2 mutation in a vestibular schwannoma arising in a patient with neurofibromatosis type 1.